Home / Market Reports / Medical Care / Global Photodynamic Therapy Drugs (PTD) Market Growth (Status and Outlook) 2024-2030

Global Photodynamic Therapy Drugs (PTD) Market Growth (Status and Outlook) 2024-2030

Global Photodynamic Therapy Drugs (PTD) Market Growth (Status and Outlook) 2024-2030

Product Code:1179150

Published Date: Apr 22,2024

Pages: 113

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic therapy, a non-invasive medical treatment that involves the administration of light-sensitive drugs followed by exposure to specific wavelengths of light to target and destroy abnormal cells, such as cancer cells or skin lesions.

The global Photodynamic Therapy Drugs (PTD) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Photodynamic Therapy Drugs (PTD) Industry Forecast” looks at past sales and reviews total world Photodynamic Therapy Drugs (PTD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Photodynamic Therapy Drugs (PTD) sales for 2023 through 2029. With Photodynamic Therapy Drugs (PTD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Photodynamic Therapy Drugs (PTD) industry.

This Insight Report provides a comprehensive analysis of the global Photodynamic Therapy Drugs (PTD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Photodynamic Therapy Drugs (PTD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Photodynamic Therapy Drugs (PTD) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Photodynamic Therapy Drugs (PTD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Photodynamic Therapy Drugs (PTD).

United States market for Photodynamic Therapy Drugs (PTD) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Photodynamic Therapy Drugs (PTD) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Photodynamic Therapy Drugs (PTD) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Photodynamic Therapy Drugs (PTD) players cover DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Photodynamic Therapy Drugs (PTD) market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Aminolevulinic Acid
    Hemoporfin
    Sinoporphyrin Sodium
    Others

Segmentation by Application:
    Pancreatic Cancer
    Esophageal Cancer
    Skin Cancer
    Lung Cancer
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Aminolevulinic Acid
    Hemoporfin
    Sinoporphyrin Sodium
    Others

Segmentation by Application:
    Pancreatic Cancer
    Esophageal Cancer
    Skin Cancer
    Lung Cancer
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    DUSA Pharmaceuticals
    Soligenix
    ORALIA
    Theralase
    Quest Pharmatech
    Biofrontera
    Merck
    QIYUE BIOLOGY
    Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
    Shanghai Guangsheng Pharmaceutical
    APExBIO Technology
    Thermo Fisher